# A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation

> **NCT01955616** · PHASE2 · TERMINATED · sponsor: **Motus Therapeutics, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** RM-131
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01955616
- **Lead sponsor:** Motus Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2015-05
- **Final completion:** 2015-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01955616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01955616, "A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01955616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*